awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39296548-65851B2F-A4B5-420F-96E3-03D3EBB77138
Q39296548-65851B2F-A4B5-420F-96E3-03D3EBB77138
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39296548-65851B2F-A4B5-420F-96E3-03D3EBB77138
Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint pha
P2860
Q39296548-65851B2F-A4B5-420F-96E3-03D3EBB77138
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39296548-65851B2F-A4B5-420F-96E3-03D3EBB77138
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
396e2a664c204db026c71113ea53676f4ccabf90
P2860
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.